BIO-key International (BKYI) Stock Price, News & Analysis

Company Overview

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

Key Stats

• Today's Range: $0.80 to $0.82
• 50-Day Range: $0.76 to $0.89
• 52-Week Range: $0.52 to $3.68
• Volume: 116,773 shs
• Average Volume: 2.33 million shs
• Market Capitalization: $4.69 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BIO-key International Stock Analysis - MarketRank™

BIO-key International scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for BIO-key International.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of BIO-key International is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of BIO-key International is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

BIO-key International has a P/B Ratio of 0.79. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.08% of the float of BIO-key International has been sold short.

Short Interest Ratio / Days to Cover

BIO-key International has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in BIO-key International has recently increased by 303.66%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

BIO-key International does not currently pay a dividend.

Dividend Growth

BIO-key International does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.08% of the float of BIO-key International has been sold short.

Short Interest Ratio / Days to Cover

BIO-key International has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in BIO-key International has recently increased by 303.66%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

1 people have added BIO-key International to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, BIO-key International insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 3.70% of the stock of BIO-key International is held by insiders.

Percentage Held by Institutions

Only 26.51% of the stock of BIO-key International is held by institutions.

BKYI Stock Analysis - Frequently Asked Questions

How have BKYI shares performed this year?

BIO-key International's stock was trading at $1.71 on January 1st, 2025. Since then, BKYI stock has decreased by 53.0% and is now trading at $0.8030.

How were BIO-key International's earnings last quarter?

BIO-key International Inc. (NASDAQ:BKYI) posted its quarterly earnings data on Thursday, May, 15th. The technology company reported ($0.16) EPS for the quarter, beating analysts' consensus estimates of ($0.24) by $0.08. The technology company had revenue of $1.61 million for the quarter, compared to analyst estimates of $1.30 million. BIO-key International had a negative net margin of 74.11% and a negative trailing twelve-month return on equity of 181.57%.
Read the conference call transcript.

When did BIO-key International's stock split?

BIO-key International's stock reverse split on Thursday, December 21st 2023.The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

How do I buy shares of BIO-key International?

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BIO-key International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BIO-key International investors own include Exxon Mobil (XOM), Onconova Therapeutics (ONTX), T2 Biosystems (TTOO), Nokia (NOK), Electrameccanica Vehicles (SOLO), Tonix Pharmaceuticals (TNXP) and iBio (IBIO).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 7/10/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: ELEC PRODS - MISC
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:BKYI
• CIK: 1019034
• Web: www.bio-key.com
• Phone: (732) 359-1100
• Fax: 732-359-1101
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($2.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$4.30 million
• Net Margins: -74.11%
• Pretax Margin: -71.61%
• Return on Equity: -181.57%
• Return on Assets: -60.78%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.32
• Quick Ratio: 1.22

Sales & Book Value

• Annual Sales: $6.93 million
• Price / Sales: 0.67
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.02 per share
• Price / Book: 0.79

Miscellaneous

• Outstanding Shares: 5,820,000
• Free Float: 5,606,000
• Market Cap: $4.67 million
• Optionable: No Data
• Beta: 0.35